All lobbying filings
AKIN GUMP STRAUSS HAUER & FELD
Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
1
-
MARA LEFEVRE New on this filingPreviously held: Leg. Asst., Sen. Hoeven (2025-2026); Leg. Aide, Sen. Hoeven (2025); Leg. Cor., Sen. Hoeven (2023-2024); Staff Asst., Sen. Hoeven (2022-2023); Intern, Sen. KCramer (2020).
Government bodies contacted
2
Lobbying activity
2
Issues related to the Small Business Innovation Research Program in the Small Business Innovation and Economic Security Act (P.L. 119-83).
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262 / S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases; Issues related to the biotech ecosystem, including most-favored-nation drug pricing; Issues related to PBM reform, PAHPA reauthorization; and PDUFA reauthorization.